Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease | Zendy

A. Boudes | Zendy; Cécile Lavoûte | Zendy; Jean-François Aviérinos | Zendy; Yvan Le Dolley | Zendy; Chloé Villacampa | Zendy; Adrien Salem | Zendy; Anderson Loundou | Zendy; Nicolas Michel | Zendy; Sébastien Renard | Zendy; Gilbert Habib | Zendy

Open Access

Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease

Author(s) -

A. Boudes,

Cécile Lavoûte,

Jean-François Aviérinos,

Yvan Le Dolley,

Chloé Villacampa,

Adrien Salem,

Anderson Loundou,

Nicolas Michel,

Sébastien Renard,

Gilbert Habib

Publication year - 2011

Publication title -

european heart journal - cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.576

H-Index - 92

eISSN - 2047-2412

pISSN - 2047-2404

DOI - 10.1093/ejechocard/jer116

Subject(s) - valvular heart disease , medicine , cardiology , disease , heart disease

Restrictive valvular disease (RVD) has recently been reported in patients after benfluorex exposure. However, little is known about its prevalence and echocardiographic features. The aim of our study was to assess the frequency of benfluorex exposure in patients with RVD and to describe their echocardiographic characteristics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research